Sabre Corpo (SABR)
Cash ratio
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash and cash equivalents | US$ in thousands | 724,479 | 668,763 | 633,652 | 650,174 | 648,207 | 601,604 | 706,148 | 817,075 | 794,888 | 782,763 | 992,180 | 1,186,410 | 978,352 | 1,023,770 | 1,122,110 | 1,284,920 | 1,499,660 | 1,668,350 | 1,306,290 | 684,472 |
Short-term investments | US$ in thousands | 555 | — | 4,269 | 4,855 | 51,970 | 6,235 | 3,374 | 3,620 | 54,303 | 3,850 | 797 | — | — | 22,698 | 23,063 | 23,889 | 24,265 | — | — | 24,503 |
Total current liabilities | US$ in thousands | 1,141,780 | 1,173,140 | 1,085,880 | 892,740 | 914,713 | 907,757 | 899,311 | 863,656 | 815,571 | 737,648 | 745,489 | 694,529 | 716,505 | 681,419 | 659,786 | 641,974 | 621,943 | 688,716 | 764,411 | 968,329 |
Cash ratio | 0.64 | 0.57 | 0.59 | 0.73 | 0.77 | 0.67 | 0.79 | 0.95 | 1.04 | 1.07 | 1.33 | 1.71 | 1.37 | 1.54 | 1.74 | 2.04 | 2.45 | 2.42 | 1.71 | 0.73 |
December 31, 2024 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($724,479K
+ $555K)
÷ $1,141,780K
= 0.64
The cash ratio of Sabre Corpo has shown fluctuations over the past few years. The cash ratio measures a company's ability to cover its current liabilities using only its cash and cash equivalents. A higher cash ratio indicates a stronger ability to cover short-term obligations with cash on hand.
Sabre Corpo's cash ratio increased from 0.73 on March 31, 2020, to a peak of 2.45 on December 31, 2020. This significant improvement suggests the company had a healthy level of cash reserves relative to its current liabilities. However, after December 31, 2020, the cash ratio started to decline gradually, reaching 0.57 on September 30, 2024.
The decreasing trend in the cash ratio may indicate that Sabre Corpo's ability to cover its short-term obligations with cash and cash equivalents has weakened over time. It is essential for investors and stakeholders to monitor this ratio closely to assess the company's liquidity position and financial health. Management should consider strategies to maintain a healthy cash ratio to ensure the company can meet its short-term financial obligations effectively.
Peer comparison
Dec 31, 2024